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Multiple Factors Modulate Biofilm Formation by the Anaerobic
Pathogen Clostridium difficile
Tanja Ðapa,a Rosanna Leuzzi,a Yen K. Ng,b Soza T. Baban,b Roberto Adamo,a Sarah A. Kuehne,b Maria Scarselli,a Nigel P. Minton,b
Davide Serruto,a Meera Unnikrishnana
Novartis Vaccines and Diagnostics, Siena, Italya; Clostridia Research Group, School of Molecular Medical Sciences, Centre for Biomolecular Sciences, University of
Nottingham, Nottingham, United Kingdomb
Bacteria within biofilms are protected frommultiple stresses, including immune responses and antimicrobial agents. The bio-
film-forming ability of bacterial pathogens has been associated with increased antibiotic resistance and chronic recurrent infec-
tions. Although biofilms have been well studied for several gut pathogens, little is known about biofilm formation by anaerobic
gut species. The obligate anaerobe Clostridium difficile causes C. difficile infection (CDI), a major health care-associated prob-
lem primarily due to the high incidence of recurring infections. C. difficile colonizes the gut when the normal intestinal micro-
flora is disrupted by antimicrobial agents; however, the factors or processes involved in gut colonization during infection remain
unclear. We demonstrate that clinical C. difficile strains, i.e., strain 630 and the hypervirulent strain R20291, form structured
biofilms in vitro, with R20291 accumulating substantially more biofilm. Microscopic and biochemical analyses showmultiple
layers of bacteria encased in a biofilmmatrix containing proteins, DNA, and polysaccharide. Employing isogenic mutants, we
show that virulence-associated proteins, Cwp84, flagella, and a putative quorum-sensing regulator, LuxS, are all required for
maximal biofilm formation by C. difficile. Interestingly, a mutant in Spo0A, a transcription factor that controls spore formation,
was defective for biofilm formation, indicating a possible link between sporulation and biofilm formation. Furthermore, we
demonstrate that bacteria in clostridial biofilms are more resistant to high concentrations of vancomycin, a drug commonly
used for treatment of CDI. Our data suggest that biofilm formation by C. difficile is a complex multifactorial process and may be
a crucial mechanism for clostridial persistence in the host.
Biofilms are sessile surface-associated microbial communities,encapsulated within self-produced polymeric matrices (1).
Biofilms represent the predominant state of bacteria in nature;
only a small fraction of bacteria in natural ecosystems are believed
to exist planktonically (2). Bacteria in biofilms are known to be
more resistant to different environmental stresses, including an-
tibiotics (2). The human large intestine is a good example of an
extremely complex ecosystem, home to numerous bacterial spe-
cies of microflora, which play an important role in protection
against gut diseases (3). Various gut pathogens, including entero-
toxigenic Escherichia coli, Salmonella, Yersinia, etc., can alter the
dynamics of the gut due to their highly adhesive and invasive
properties (4) and thus establish infections. Biofilm formation by
gut pathogens such as enteroaggregative E. coli has been well stud-
ied both in vitro and in vivo (5, 6). Several bacterial factors such as
adhesins and pili, which mediate biofilm formation, have been
implicated in bacterial colonization and virulence (7).
Biofilm formation has been characterized for very few individ-
ual bacterial gut species of the numerous anaerobic species that
populate the gut. This could be attributed to difficult cultivation
and geneticmanipulation of such bacteria.Clostridium difficile is a
spore-forming, Gram-positive anaerobic bacillus that can causes
severe gastrointestinal infections in humans (8). C. difficile infec-
tion (CDI) is usually associatedwith antimicrobial therapy since it
results in disruption of the normal microbiota. The clinical symp-
toms of CDI range frommild or severe diarrhea to serious inflam-
matory conditions, including pseudomembranous colitis (8).
CDI is one of the predominant nosocomial infections worldwide
today. The population with the largest risk for CDI is the elderly,
although CDI in younger patients is on the rise (9). The transmis-
sion of clostridial disease occurs through spores, as demonstrated
recently using a murine model for C. difficile infection (10, 11).
CDI is primarily a toxin-mediated disease. The two large clos-
tridial toxins A (TcdA) and B (TcdB) are the best-characterized
virulence factors ofC. difficile (12–15).C. difficile toxins have been
shown to have many effects, including disorganization of the cell
actin cytoskeleton and tight junctions, induction of apoptosis,
fluid accumulation, and destruction of the epithelium (14, 15).
Although the toxins are key virulent factors, a role for bacterial
colonization has been highlighted in recent years. Mice immu-
nized with C. difficile surface proteins demonstrated reduced in-
testinal colonization with C. difficile (16). Recently, the fibronec-
tin-binding adhesin protein A was shown to play a role in C.
difficile colonization (17). The high- and low-molecular-weight
surface layer proteins (SLPs) are predicted to be involved in ad-
herence of C. difficile to host cells during the infection (18, 19).
Cell wall proteins (CWPs) such as Cwp66 and Cwp84 have been
shown to be important in the adherence and degradation of the
extracellular matrix (20, 21).
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Recurrent bacterial infections have been associated with the
ability to form resilient biofilms for various pathogens (22). Per-
sistent recurringC. difficile infections have presented amajor hur-
dle in the treatment of CDI (23). The ability to form biofilms has
been demonstrated recently for related clostridial species and for
C. difficile in relation to other intestinal species (24, 25). However,
biofilm formation by C. difficile, or the mechanisms involved in
this process, has not yet been characterized. We describe biofilm
formation by clinical C. difficile strains in vitro using multiple
techniques. Using isogenic mutants of proteins associated with
clostridial pathogenesis we have identified surface and regulatory
proteins that are required for biofilm development by the hyper-
virulent strain R20291. We also report a role for C. difficile bio-
films in resistance to antibiotics commonly used for the treatment
of CDI.
MATERIALS AND METHODS
Bacterial strains and media. Two C. difficile strains, 630 and strain B1/
NAP1/027 R20291 (isolated from the Stoke Mandeville outbreak in 2004
and 2005), were used in our studies.C. difficile strains were grown at 37°C
in an anaerobic workstation (Don Whitley, United Kingdom) in BHIS,
brain heart infusion (Bacto, USA) supplemented with L-cysteine (0.1%
(wt/vol), and yeast extract (5 mg/ml; Bacto, USA). Details about antibi-
otics are described in the supplemental material. Table S1 in the supple-
mental material lists the strains and plasmids used in the present study.
Biofilm formation assay. For the generation of biofilms, overnight
cultures ofC. difficilewere diluted 1:100 into fresh BHIS, containing 0.1M
glucose or 0.3MNaCl, and incubated in the tissue culture treated 24-well
polystyrene plates (Costar, USA), 1ml per well, in anaerobic conditions at
37°C for 1 h to 120 h. Twenty-four-well cell culture plates were preincu-
bated in anaerobic conditions for 48 h prior to use. To prevent evapora-
tion of liquid, the plates were wrapped with parafilm.
Measurement of biofilm biomass. Measurement of biofilm biomass
with crystal violet (CV) was done as described in previously published
methods (24). After the required incubation, wells of the 24-well plate
were gentlywashed twicewith sterile phosphate-buffered saline (PBS) and
then allowed to dry for 10 min. The biofilm was stained with 1 ml of
filter-sterilized 0.2% CV and incubated for 30 min at 37°C in anaerobic
conditions. CV was removed from the wells, followed by two washes with
sterile PBS. The dyewas extracted by adding 1ml ofmethanol to eachwell,
followed by incubation for 30 min at room temperature in aerobic con-
ditions. The methanol-extracted dye was diluted 1:1, 1:10, or 1:100 and
A570 was measured with spectrophotometer Ultrospec 500pro (Amer-
sham Biosciences).
For bacterial cell counts from biofilms, the planktonic phase was first
removed and wells were washed twice with PBS. The adherent biofilms
were then detached by scraping with a sterile pipette tip, washed in PBS,
and plated on BHIS for determination of the number of CFU present in
the biofilm.
Enzymatic inhibition of biofilms. To study whether enzymes affect
the biofilm formation, 0.1 mg of proteinase K/ml and 2 U of DNase I/ml
was added to biofilms at time zero. To see whether these enzymes affect
preformed biofilms, biofilms were allowed to form in 24-well plate as
described above, washed twice with sterile PBS. Fresh BHIS plus 0.1MGlc
with 0.1 mg of proteinase K/ml or 2 U of DNase I/ml was added, and the
biofilms were incubated for a further 24 h, followed by staining with 0.2%
CV as described above.
Confocal microscopy analysis of biofilm formation. C. difficile
strains were grown in 4-well glass chamber slides (BD Falcon, USA) in
BHIS plus 0.1Mglucose at 37°C in anaerobic conditions for 24 or 72 h and
then stained with various staining reagents. For biofilm staining with the
fluorescent BacLight Live/Dead stainmixture (Molecular Probes/Invitro-
gen), which contains the nucleic acid stains Syto 9 and propidium iodide,
wells were gently washed twice with PBS–0.1% saponin to remove unat-
tached cells, followed by incubation with dye for 15 min at 37°C. Before
removal from the anaerobic chamber, the bacteria were fixed with 4%
paraformaldehyde (PFA) for 15 min.
For immunofluorescent staining bacteria were fixed with 4% PFA for
15 min, washed three times with 2% bovine serum albumin (BSA)–PBS,
and blocked with 2% BSA and 0.1% saponin in PBS for 10 min. The
samples were then incubated with mouse serum against fixed R20291
strain or against a synthetic C. difficile PSII polysaccharide (synthetic
phosphorylated hexasaccharide repeating unit) (26) diluted 1:1,000 for 1
h, followed by incubation with Alexa Fluor 568 goat anti-mouse antibod-
ies diluted 1:500 for 1 h.
Biofilmmatrix was labeled by SYPRORuby biofilmmatrix stain (Mo-
lecular Probes/Invitrogen), which stains matrices of biofilms (labels most
classes of proteins, including glycoproteins, phosphoproteins, lipopro-
teins, calcium-binding proteins, and fibrillar proteins). After two washes
with sterile PBS–0.1% saponin sample were incubated for 30 min with 1
ml of Ruby biofilm matrix stain at room temperature and then washed
with distilled water.
All chamber slides weremountedwith ProLongGoldAntifade reagent
(Molecular Probes/Invitrogen) and analyzed with a Zeiss Observer LSM
710 confocal scanning microscope.
Construction of C. difficile mutants and complemented strains.
Mutations in the genes sleC, spo0A, fliC, and luxSwere generated using the
insertional inactivation system, ClosTron, as previously described (27–
30). Construction of the fliC and luxSmutants is described in the supple-
mental material. The positions of in-frame deletions and ClosTron inser-
tions are reported in Table S1 in the supplemental material. To generate
the cwp84mutant, the 3= end of the cwp84 genewas deleted by using allelic
exchange as described elsewhere (Y. K. Ng et al. unpublished data). Com-
plementation studies are described in the supplemental material.
Measurement of C. difficile spores in biofilm. C. difficile spores were
measured as previously described (27). At day 1, 3, and 5 of biofilm for-
mation samples were removed from the anaerobic chamber and heated at
80°C for 25 min to kill the vegetative cells but not the spores. Serially
diluted were then plated onto BHI agar and BHI supplemented with
0.1% taurocholate (Sigma-Aldrich, USA). The plates were incubated
for 24 to 48 h.
Biofilm resistance to antibiotics. To determine the resistance capa-
bilities of planktonic and biofilm cells, we used antibiotic vancomycin
(Sigma-Aldrich) at 100 times theMIC (theMIC was determined to be 0.2
g/ml for R20291 [data not shown]). Resistance was determined to both
sessile and planktonic populations from the same C. difficile culture. The
supernatant (planktonic fraction) from 1- or 3-day biofilm cultures in
six-well plates was removed, washed once in sterile PBS, resuspended in
BHIS–0.1 M glucose with 20 g of vancomycin (Sigma-Aldrich)/ml, and
incubated in fresh six-well plates. In parallel, to six-well plate where su-
pernatants were removed, fresh BHIS–0.1 M glucose containing 20 g of
vancomycin/ml was added to the adherent biofilms (sessile part). Treat-
mentwith vancomycinwas performed for 6 or 24 h. CFU fromplanktonic
and adherent phases were determined by plating dilutions on BHIS agar.
Biofilm cell counts were determined as described above. The percent sur-
vival was calculated by dividing the number of CFU posttreatment by the
initial number of CFU.
To investigate whether the protection from vancomycin is a result of
biofilm structure or a physiological attribute of the cells in the biofilm, we
perform experiment as described above. The sessile part of biofilm was
disrupted gently by pipetting and incubatedwith BHISwith 0.1MGlc and
20 g of vancomycin/ml. The planktonic growth from the same well was
washed and incubated with BHIS with 0.1 M Glc and 20 g of vancomy-
cin/ml. CFU counts were determined after 6 and 24 h, and counts before
and after different times of treatment were compared.
Statistical analyses. All biofilm experiments were performed in trip-
licates and at least three independent experiments were performed. A
paired Student t test was performed to determine whether the differences
Ðapa et al.
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between two groups was significant. P values of 0.05 were considered
statistically significant.
RESULTS
C. difficile forms time- and strain-dependent biofilms in vitro.
In order to investigate biofilm formation byC. difficile, we studied
two strains,C. difficile 630, a commonly studied clinical strain, and
the hypervirulent strain R20291. Sessile biomass (biofilm) was
measured by staining the biofilms with CV, as described in Mate-
rials and Methods. We tested biofilm formation in several media
(chemically definedmedium, richmediumTYM, and BHIS) sup-
plemented with combinations of sodium chloride and glucose
(data not shown). Both strains form higher amounts of biofilm in
rich medium BHIS supplemented with 0.1 M glucose. In the ab-
sence of glucose, strain 630 forms significantly lower amounts of
biofilm compared to that seen in the presence of 0.1 M glucose.
However, the presence of glucose does not significantly affect bio-
film formation for the strain R20291. The presence of 0.3 M so-
dium chloride inhibits biofilm formation in both strains (Fig. 1A).
Biofilms formed in all conditions tested were adherent in na-
ture and were found to form only on the bottoms of the wells (of
24-well plates) and not on the surface of the culture medium.
Biofilm formation in BHIS containing 0.1 M glucose was moni-
tored over a time period of 1 to 120 h and quantitated by both CV
staining and bacterial counts.C. difficile 630 biofilm accumulation
appears to be maximal at day 5 (120 h) (Fig. 1B). Strain R20291
starts to form biofilm after 6 h of incubation, with maximum
biofilm formation after 24 h, as measured by CV staining
(Fig. 1C). Biofilm formed by the strain R20291 uniformly covers
the entire surface area of the bottom of the wells (24-well plate) at
24 h (Fig. 1D), while at the same time point for strain 630 (Fig. 1D)
we saw much less biofilm formation. At 72 h (Fig. 1E), we ob-
served relativelymore uniform biofilms for strain 630 and uneven
biofilms for strain R20291 (Fig. 1E). Bacterial counts from bio-
films indicated a similar trend of increasing bacterial numbers
until 24 h and a decrease after this period for both strains. How-
ever, it is clear that R20291 biofilms have significantly higher
number of bacteria as well as higher amounts of biofilms as quan-
titated by CV, compared to 630, under the conditions tested.
C. difficile biofilms are multilayered and encased in a thick
matrix. To examine biofilm formation by strains R20291 and 630
further, biofilms were allowed to form on glass slides in BHIS
containing 0.1 M glucose for one or 3 days. Live/Dead staining
(with Syto 9 and propidium iodide dyes staining live bacteria
green and dead bacteria red, respectively) was used in order to
evaluate the bacterial viability and biofilm thickness. We found
that the majority of bacteria in both R20291 (Fig. 2A and B) and
630 (Fig. 2C and D) biofilms were alive with a minor number of
dead cells after 1 day (Fig. 2A and C) and 3 days (Fig. 2B and D).
Z-stack acquisitions revealed multiple layers of bacteria in the
biofilm underneath a dense layer of material (Fig. 2A to D, right
panels). Three-dimensional (3D) images show the presence of
uniformly spread biofilms for R20291 on day 1 (Fig. 2A), with
uneven secondary structures by day 3 (Fig. 2B), and with a thick-
ness ranging from 30 to 45m. For strain 630, we observe that the
Live/Dead staining of biofilms was not homogeneous as seen for
R20291 after day 1 (Fig. 2C) or day 3 (Fig. 2D). The maximum
thickness of the biofilm was 30 m (72 h). Thus, microscopic
analysis suggests that C. difficile biofilms are structured, with sev-
eral layers of largely live bacteria encased within a dense matrix.
Composition of the C. difficile biofilm matrix. Since the
R20291 biofilms were more robust and reproducible, we exam-
ined the R20291 biofilms further using multiple staining to eval-
uate the extracellular matrix. Interestingly, antibodies against
FIG 1 C. difficile biofilm formation in vitro. (A) Biofilm formation by strain 630 and
hypervirulentstrainR20291,inBHISsupplementedwith0.1Mglucoseor0.3MNaCl,
for 3 days at 37°C in anaerobic conditions. Biofilm formation was measured by CV
staining. (B andC)Time course for biofilm formation for strains 630 (B) andR20291
(C)measuredbyCVstaining(bars) andcolonycounts (CFU/ml, line).Theresults are
presented in logscale, andtheerrorbars represent standarddeviations(P0.05).The
data are representative of at least three independent experiments, each performed in
triplicates. (DandE)Photographsofbiofilmsformedona24-wellplate for strains630
andR20291 onday 1 (D) andday 3 (E) are shown.
C. difﬁcile Bioﬁlm Formation Is Multifactorial
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whole bacteria were able to stain a complex biofilm matrix and
some superficial individual bacteria (Fig. 3A). The formation of a
thick mature biofilm was visualized by a biofilm matrix tracer
Ruby stain, which labels a range of protein classes including gly-
coproteins, lipoproteins, and phosphoproteins (Fig. 3B). In addi-
tion, when using staining with an antibody against a synthetic C.
difficile PSII polysaccharide (synthetic phosphorylated hexasac-
charide repeating unit) (26), we observed staining of fiber-like
structures on biofilms (Fig. 3C). To confirm whether proteins are
part of biofilm matrix, we treated biofilms with 0.1 mg of protei-
nase K/ml. Although planktonic growth was not inhibited by pro-
teinase K (see Fig. S1 in the supplemental material), incubation of
the bacterial cultures with the enzyme resulted in a significant
decrease in biofilm formation on days 1 and 3, with protease (Fig.
3E, dark-shaded bars). One-day-old biofilms were also disrupted
when treated with proteinase K (Fig. 3E, light-shaded bars). We
also performed similar experiments with DNase I treatment and
found that DNase I also inhibited biofilm formation (Fig. 3F,
dark-shaded bars) and is able to reduce preformed biofilms
(Fig. 3F, light-shaded bars), although to a lesser degree compared
to proteinase K. These results indicate that bacterial proteins,
DNA, and surface polysaccharide are components of the biofilm
matrix formed by C. difficile in vitro.
An intact S layer and flagella are important in C. difficile
biofilm formation. Numerous cell surface proteins and surface
FIG 2 Confocal microscopy analysis of biofilms formed by C. difficile. Live/
Dead staining shows dead (red) and live (green) bacteria (propidium io-
dide and Syto 9, respectively) in strains R20291 (A and B) and 630 (C and
D) biofilms after incubation for 1 day (A and C) and 3 days (B and D). 3D
images of biofilms depicting biofilm thickness in m are shown in the left
panels.
FIG 3 Characterization of C. difficile biofilm matrix. (A) shows 3D confocal
microscopy images of staining of R20291 biofilms with murine anti-R20291
(left panel) andmouse preimmune serum (right panel) after 3 days of incuba-
tion. (B) Biofilms stained with Ruby matrix stain after 3 days of incubation.
Biofilms were stained with antibodies to a synthetic C. difficile PSII polysac-
charide (red) andDAPI (blue), which stains the bacterial DNA (C), or with the
control mice preimmune serum and DAPI (D). Biofilms were incubated with
proteinase K (E) or DNase I (F) as described in Materials and Methods. The
dark gray bars represent data from treatment of either enzyme at the start of
incubation (inhibition of biofilm formation), and the light gray bars represent
data from incubating preformed 1-day-old biofilms with either enzyme (dis-
ruption of biofilms). The data shown are representative of at least two inde-
pendent experiments performed in triplicates (P 0.05).
Ðapa et al.
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structures such as flagella and pili have been shown to be important
for biofilm formation inGram-positive bacteria. Cwp84 is a key sur-
face protease involved in maturation of the S layer of C. difficile. We
compared biofilm formation of a strain with a deletion of the cwp84
gene, CdiR20291cwp84 (cwp84), with the wild type (WT) using
multiple methods. Although there was no defect in planktonic
growth (see Fig. S2 in the supplemental material), we saw a dramatic
decrease in biofilm accumulation for cwp84 strain, as measured by
CV staining (Fig. 4A). The cwp84 mutant showed a more dramatic
defect in biofilm formation on day 1 compared to days 3 and 5. Mi-
croscopic analysis showed a single layer of bacteria for cwp84 strain
(Fig. 4C, panel 2) compared to theWT(Fig. 4C, panel 1).Thebiofilm
defect for the cwp84 strain was fully complemented by restoring the
WT gene on the chromosome CdiR20291cwp8-C (referred to here
as cwp84-C, where the suffix “-C” indicates that the gene is comple-
mented).
To examine the role of flagella, a mutant in the flagellin gene,
fliC, CRG3351 (fliC), was tested for biofilm formation. We ob-
served a significant decrease in biofilm accumulation for the fliC
mutant compared to the WT on day 5 but not at earlier times
using CV staining (Fig. 4B) and microscopic analysis (Fig. 4C,
panel 4). This was reversed upon expressing the FliC protein epi-
somally from its native promoter (fliC-C) (Fig. 4B). No differ-
ences in planktonic growth were observed between these strains
(data not shown). These data may indicate that while a mature S
layer is important in early biofilm stages such as adhesion, flagella
may be more important for later stages in biofilm formation.
A putative role for quorum sensing in biofilm formation.
Quorum sensing plays a vital part in biofilm formation, and the
involvement of quorum sensing regulators such as luxS has been
demonstrated for various other bacteria (31–33).We tested amu-
tant of a luxS, homologue in C. difficile, by homology to other
Gram-positive bacteria. A dramatic defect in biofilm formation
was observed for the luxS mutant, CRG1183 (luxS), both by CV
staining (Fig. 5A) and by microscopy (Fig. 5B, center panel), with
no significant differences at different times after incubation (data
not shown). Examination of the luxS mutant showed that it is
unable to form even a bacterial monolayer on glass surface. Bio-
film defects of this mutant were complemented by episomal ex-
pression of the full-length gene under the control of the native
promoter (luxS-C). Although the complementation did not com-
pletely restore the WT phenotype, we were able to detect several
layers of bacteria for the complemented strain (Fig. 5B, right
panel). Although the growth curves for mutant and comple-
mented strains were similar (see Fig. S3 in the supplemental ma-
terial), it is possible that expressing luxS episomally may be toxic
for the bacteria, since we observed a smaller colony size for this
strain on plates (data not shown).
Sporulation/germination pathway mutants are defective in
biofilm formation. Sporulation is a key pathway that is initiated
FIG 4 Role of S layer and flagella in biofilm formation. (A) Biofilm formation byWTR20291, a cwp84mutant (cwp84) for days 1, 3, and 5 and a complemented
strains (cwp84-C) for day 1 in vitro as measured by CV staining. (B) Biofilm formation byWT R20291, fliCmutant (fliC) for days 1, 3, and 5 and complemented
strains fliC (fliC-C) for day 5 in vitro asmeasured by CV staining. (C) Confocal microscopy images of Live/Dead staining of biofilms formed by theWT,cwp84,
cwp84-C, and fliC. The results are presented in log scale, and the error bars represent standard deviations (P 0.05). Biofilm assays were performed in triplicates,
and data are representative of at least three independent experiments.
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byC. difficile under conditions of stress. Regulators of sporulation
such as Spo0A are also involved in formation of biofilms in other
Gram-positive bacteria (34). We first studied whether spore for-
mation occurs inC. difficile biofilms in our growth conditions, for
adherent biofilms and planktonic phase from the same well of the
24-well plate (Fig. 6A). We found that there are very few spores in
the biofilm (0.0001%) and in planktonic phases (none detectable)
on day 3 and day 5 (0.0001%, data not shown). However, in the
control, which was bacteria cultured in a tube (where biofilm for-
mation did not occur), spores were formed by day 3 (40 to 50%)
(Fig. 6A). Nevertheless, a spo0Amutant CRG1375 (spo0A), which
is defective in sporulation (see Fig. S5A in the supplemental ma-
terial), demonstrated significantly lesser biofilm formation com-
pared to WT both by CV staining (Fig. 6B) and microscopy
(Fig. 6D, panel 2) at day 1 and days 3 and 5 (data not shown). We
also tested a mutant for a protein involved in C. difficile germina-
tion, CRG1166 (sleC) (Fig. S5B). The sleC mutant is able to form
biofilm-like structures (Fig. 6C), but the biofilm is uneven and the
thickness of biofilm produced by this strain is never more than 20
m (Fig. 6D, panel 4). The cellular morphology of the bacteria in
these biofilms is different to wild-type, and appears to form fila-
mentous structures. Biofilm defects of both mutants were com-
plemented by episomal expression of genes spo0A or sleC (spoA-C
and sleC-C) under the control of their respective native promoters
(Fig. 6B to D).
In addition to the ClosTron mutants described above (fliC,
luxS, spo0A, and sleC), other mutants in the binary toxins, cdtA
and cdtB, or germination-specific N-acetylmuramoyl-L-alanine
amidase, cwlD (generated using ClosTron) were also tested, but
did not display significant defects in biofilm formation (data not
shown).
Effects of vancomycin on C. difficile biofilms. Since biofilms
are known to be a means by which bacteria protect themselves
from antibiotics, we studied whether C. difficile biofilms are im-
portant in mediating antibiotic resistance. We tested the resis-
tance of bacteria in biofilms to the antibiotic vancomycin, which is
commonly used for the treatment of CDI. In vitro, vancomycin,
has excellent activity against C. difficile; an MIC of 0.75 to 2.0
g/ml is sufficient to inhibit 90% of strains (23). Both sessile and
planktonic phases, from the same C. difficile biofilm culture,
1-day-old (see Fig. S6A in the supplemental material) and 3-day-
old biofilms (see Fig. S6B in the supplemental material) were ex-
posed to 20 g of vancomycin/ml (100 times the MIC of strain
R20291) for 6 and 24h as described inMaterials andMethods. The
percentages of surviving bacteria after treatment with antibiotics
for 24 h for 1-day-old and 3-day-old biofilms are presented in Fig.
7A. Bacteria in 1-day-old and 3-day-old biofilms survived 5- and
12-fold more, respectively, than planktonic bacteria. These data
support a role for C. difficile biofilms in resisting antibiotics.
To try and understand whether resistance to vancomycin is
due to protection conferred by biofilm matrix structure or an
inherent property of the bacteria in biofilm, we studied the effect
of vancomycin on adherent biofilms that were disrupted by
pipetting (Fig. 7B). Disrupted sessile biofilm and the planktonic
phase from 1-day-old biofilm were incubated for 6 and 24 h with
20 g of vancomycin/ml. Bacteria from the disrupted adherent
biofilms were not more resistant to high concentrations of antibi-
otics of biofilm compared to bacteria from the planktonic phase.
Although the bacteria from disrupted biofilms do not form new
adherent biofilms after the incubation with antibiotics even after
48 h of incubation (data not shown), we observe unstable, thread-
like structures in the wells (which were disrupted by pipetting
before performing CFU counts). The lack of antibiotic resistance
by disrupted biofilm bacteria may indicate a lack of genetic
FIG 5 Potential role for quorum sensing in C. difficile biofilm formation. (A) Biofilm formation by WT R20291, putative quorum-sensing gene luxS mutant
(luxS), and complemented strains (luxS-C) as measured by CV staining. (B) Confocal microscopy analysis of WT, luxS, and complemented strain luxS-C. The
results are presented in log scale, and the error bars represent the standard deviations (P 0.05). The data from biofilm assays are representative of at least three
independent experiments performed in triplicates.
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changes in the bacteria within resistant biofilms and suggest that
the biofilm matrix and/or other epigenetic mechanisms are in-
volved in mediating vancomycin resistance.
Biofilm formation, on the other hand, has been reported to be
stimulated by subinhibitory concentrations of antibiotics (35). To
study whether vancomycin stimulates the biofilm formation in
vitro, bacteria were treated with a range of concentrations of van-
comycin (0 to 0.5 g/ml), both lower and higher than the tube
growthMIC (0.2 g/ml), and biofilm formation was measured at
day 1 and day 3. No significant induction of biofilm was observed
for any of the vancomycin concentrations after 1 day. Inhibition
of biofilm formation was evident for concentrations of vancomy-
cin of0.5g/ml (Fig. 7C). Interestingly, after 3 days incubation,
a significant induction of biofilms was observed with 0.5 g of
vancomycin/ml and to a lesser extent with a subinhibitory con-
centration (0.25 g/ml) of vancomycin (Fig. 7C). These results
FIG 6 Sporulation/germination proteins affect C. difficile biofilm formation. (A) Quantitation of the number of spores present in the adherent, planktonic
phases of biofilmand in planktonic tube culture, in brain heart infusionmedia (BHI)with sodium taurocholate (BHIT) andheat treatment (80°C), as described
inMaterials andMethods. (B andC) Biofilm formation byWTR20291, sporulation transcription factor spo0Amutant (spo0A) and complemented spo0Amutant
(spo0A-C) after 1 day (B) andWTR20291, sleCmutant (sleC) and complemented sleCmutant (sleC-C) after 3 days (C). (D) Confocalmicroscopy analysis ofWT
and mutants spo0A, complemented spo0A mutant (spo0A-C), and sleC. The results are presented in log scale, and the error bars represent standard deviations
(P 0.05). Both biofilm and spore quantitation experiments were performed in triplicates, and the data shown are representative of at least three independent
experiments.
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suggest that exposure to inhibitory vancomycin concentrations
can stimulate biofilm formation in vitro.
DISCUSSION
Biofilms are the most representative form of growth of bacteria in
the large intestine (4). The ability to form biofilms is known to
influence the virulence and also the transmission of intestinal
pathogenic bacteria such asVibrio cholerae (36–38). In the present
study, we report for the first time the ability of two clinically rele-
vant Clostridium difficile strains, “nonepidemic” strain 630 and
“epidemic” hypervirulent strain R20291, to form structured bio-
films in vitro. Furthermore, we identify several genes that may
influence C. difficile biofilm development.
The ability to adhere and formbiofilms influences the ability of
pathogens to colonize and establish an infection (39, 40). Our data
show that R20291 forms more biofilm in all tested conditions in
vitro. It has been reported that strain R20291, a hypervirulent
strain, produces higher levels of toxin in vitro compared to 630
(41). Although colonization of these strains has yet to be examined
carefully in vivo, higher biofilm formation by this strain could
indicate better colonization in vivo. While for the strain R20291
addition of glucose does not increase the levels of biofilm forma-
tion, it is an important factor for biofilm formation for strain 630.
It is well known that different carbohydrates canmodulate biofilm
formation. Carbohydrates induce biofilm formation in Strepto-
coccus gordonii (42), while in Bacillus subtilis the CcpA protein
represses formation of biofilm in medium with high levels of glu-
cose (43). It is possible that in vivo the nutritional environment in
the gut modulates colonization of C. difficile.
The biofilm matrix is known to protect bacteria during infec-
tions by providing an enclosed environment to escape immune
responses (5, 36). Similar tomany clinically relevant biofilm form-
ers such as Pseudomonas aeruginosa and Staphylococcus aureus, C.
difficile also appears to form a complex matrix comprising of pro-
teins, DNA and polysaccharide (44–46). Staining with antibodies
against C. difficile suggests that this compact biofilm may com-
prise surface-associated or secreted bacterial components and
may be impenetrable to antibodies. Furthermore, it is interesting
that we observe biofilm matrix staining for a synthetic derivative
of the C. difficile surface PSII polysaccharide, which was recently
reported to be immunogenic (26). The presence of a complex and
perhaps impermeable matrix may protect C. difficile from unfa-
vorable agents in vivo in the gut.
Regulation of biofilm formation in Gram-positive bacteria in-
volvesmultiple factors including adhesins, surface structures such
as flagella and pili (47). The C. difficile S layer is composed of
S-layer proteins (SLPs) that are present as heterodimeric complex
(48). The signal peptide of protein precursor SlpA is removed by
proteolytic cleavage. Additional cleavage is essential for matura-
tion of SLPs, which is mediated by the cysteine protease Cwp84
(49, 50). A mutant in cwp84 has previously been shown to be
FIG 7 Effect of antibiotics on C. difficile biofilms. (A) Clostridium difficile 1- to 3-day-old biofilms and the corresponding planktonic growth were exposed to 20
g of vancomycin/ml (100 times theMIC) for 24 h. The data are presented as percentage of surviving bacteria after treatment with antibiotics for 24 h for 1- and
3-day-old biofilms. (B) Bacterial counts from disrupted 1-day-old biofilms were incubated with 20 g of vancomycin/ml for 6 h or 24 h. (C) Biofilm formation
measured by CV staining at days 1 and 3 after treatment with subinhibitory and inhibitory concentration of antibiotic vancomycin (MIC for R20291 was 0.2
g/ml). The results are presented in log scale, and the error bars represent standard deviations (P  0.05). An asterisk (*) denotes significant differences
compared to biofilm formation in the absence of vancomycin (0 g/ml).
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defective in the S-layer synthesis (50). This protease is also impor-
tant for the degradation of extracellular matrix proteins such as
fibronectin, laminin, and vitronectin (21). Our data prove that a
mature S layer is essential for C. difficile biofilm formation, per-
haps due to the fact that this layer may be essential for anchoring
various cell wall associated proteins, which may be required for
the early steps such as adhesion during biofilm formation. A role
for specific CWPs in biofilms remains to be investigated. Further-
more, the observation that antibodies raised against fixed whole
bacteria recognize complex structures on biofilms may indicate
that surface components such as CWPs may compose the biofilm
matrix.
Bacterial flagella are known to modulate attachment, the first
step in biofilm formation in motile bacteria, however, the precise
role varies between species. For Gram-positive bacteria such as B.
subtilis the presence of flagella is important but not essential for
formation of biofilms (51), while for Listeria monocytogenes, mo-
tility is essential for mature biofilm formation (52). In our exper-
iments a mutant in flagellin, a principal component of flagella,
clearly affects biofilms in vitro, indicating that motility of C. diffi-
cile is key in formation of biofilms. Recently, strain 630 C. difficile
flagellar mutants were reported to have better adherence in an in
vitromodel (53). Our data further suggest that flagella are impor-
tant at later biofilm stages, as the mutant does not display defects
in our in vitro assays at earlier time points.
Cell-cell communication is crucial in a complex structure like
biofilms where bacteria are in strict contact with one another.
Quorum sensing has an important role in bacterial biofilm forma-
tion (33, 54). The enzyme LuxS, that synthesizes autoinducer-2
(AI-2), is one of the major modulators of QS and is largely con-
served across bacterial species (55). It was demonstrated that C.
difficile genome carries a 453-bp gene that encodes a proteinwhich
shares 40% identity to the V. harveyi LuxS protein and is respon-
sible for AI-2 production (56). The role of luxS in toxin produc-
tion is not clear as there are conflicting reports in the literature (56,
57). While precise mechanisms by which luxS functions in C. dif-
ficile is unclear at present, our data suggest a role for putative
luxS-encodedmolecules in formation of biofilms in vitro andmay
indicate that a luxS-mediated quorum-sensing system exists in C.
difficile.
Sporulation is a critical pathway in bacterial responses to envi-
ronmental stresses. Spo0A is the main response regulator which
controls entry into sporulation and is well conserved in Bacillus
and Clostridium species (58, 59). Spo0A is also known to regulate
a range of regulatory factors, thus affecting pathways unrelated to
sporulation (60). C. difficile spo0Amutants have been reported to
modulate toxin production, although there are contradictory data
about the nature of this regulation (11, 59). Although we do not
know yet if there is a link between toxin production and biofilms,
clearly C. difficile spo0A is involved in the formation of biofilms in
vitro. Biofilm environments have been shown to be optimal for
spore formation and spores are part of biofilms for many spore-
forming bacteria under nutrient-starved conditions (47). How-
ever, we find extremely low numbers of spores in biofilms (adher-
ent and planktonic phases of biofilms) under our conditions.
Previously, Hamon et al. demonstrated that a B. subtilismutant of
spo0A was defective for biofilm formation, and similar to our ob-
servation, they did not detect spores in Bacillus biofilms in vitro
(34). We hypothesize that spo0A in C. difficile acts as a switch
between different stress-related pathways such as sporulation,
biofilm formation, and toxin production. Our observation that
bacteria sporulate during tube culture, but not in biofilms, when
incubated under similar conditions, may support this hypothesis.
Recently, spo0Amutants were shown to be defective in persistence
and transmission in a murine infection model, primarily due to
the inability of the spo0A mutant strain to form spores (11). In
addition to production of spores, the formation of biofilms in vivo
may also account for the persistence defects observed for the
spo0A strain. Indeed, under other in vitro conditions or in vivo,
spores may also form part of biofilms.
Interestingly, we find that a mutant lacking SleC, a protein
recently reported to be specifically involved in germination of C.
difficile spores (27), is defective for biofilm formation. A role for
spore germination in biofilms has not been well studied; however,
in our conditions given the lack of spores, it is unlikely that SleC is
involved in germination of spores. Given that the sleC mutant
biofilms shows strikingly different cellularmorphologies, it is pos-
sible that SleC has other functions such as in hydrolysis of vegeta-
tive cell peptidoglycans.
The relevance of biofilm formation in the context of infection
and treatment has been widely studied. The role of biofilms in
mediating resistance to antibiotics had been well studied for sev-
eral bacteria, e.g., methicillin-resistant S. aureus (61). Resistance
to antibiotics in biofilm can increase from 10- to 1,000-fold more
compared to planktonic bacteria (62). The rising incidence of re-
sistance to antibiotic treatments for nosocomial pathogens such as
S. aureus and C. difficile has been well documented in recent years
(63). Highly antibiotic-resistant C. difficile strains and treatment
of recurring clostridial infections have been the major challenges
for managing CDI (23). Our findings indicate that C. difficile bio-
films are more resistant to the antibiotic vancomycin, which is
commonly used for treatment of CDI. Furthermore, our initial
studies on the mechanisms involved in antibiotic resistance show
that the bacteria from resistant biofilms do not appear to carry
inheritable changes and may suggest a role for the C. difficile bio-
film matrix structure in antibiotic penetration, as seen for other
bacteria (62). It is also possible that the physiological state of bac-
teria within biofilms is important in mediating resistance (64).
Interestingly, lower concentrations of vancomycin induce biofilm
formation. A role for antibiotics in stimulating biofilm formation
has been examined previously for other bacteria and second mes-
senger signaling involving c-di-GMP has been implicated in this
process (35, 65). It is believed that such an induction of biofilms
could be clinically relevant when there is exposure to low doses of
antibiotics, e.g., the beginning and end of antibiotic therapy, and
could perhaps explain ineffective treatment (65). In CDI, the es-
tablishment of persistent biofilms in vivo, in addition to the for-
mation of spores, could potentially explain the occurrence of re-
current infections.
In conclusion,we demonstrate that clinically relevant strains of
the anaerobic gut pathogen C. difficile are able to form complex
biofilms in vitro. C. difficile biofilm formation appears to be a
multifactorial process with a role for proteins that are important
in different aspects of bacterial physiology. Indeed, the details of
the precise roles of each of these proteins/pathways and their reg-
ulation remain to be studied. A possible model of infection is that
C. difficile colonizes the colon via formation of microcolonies or
biofilms, followed by toxin production. Formation of biofilms in
vivo perhaps provides the bacterium with a mechanism to protect
itself from the cellular immune responses invoked by the toxins, in
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addition to a mechanism of persistence in the presence of antibi-
otics. Investigation of C. difficile biofilm development during in-
fection and factors controlling it could give us a better insight into
their role in C. difficile pathogenesis.
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